美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Veraxa Biotech Holding AG

1.95

+0.06003.17%

盘前：2.000.0500+2.56%04:00 EDT

成交量：8.01万

成交额：15.56万

市值：2.76亿

市盈率：9.10

高：2.00

开：1.86

低：1.85

收：1.89

52周最高：27.36

52周最低：1.70

股本：1.41亿

流通股本：4,101.25万

量比：0.97

换手率：0.20%

股息：- -

股息率：- -

每股收益(TTM):0.2142

每股收益(LYR):-2.2094

净资产收益率：-65.29%

总资产收益率：-20.46%

市净率：7.12

市盈率(LYR):-0.88

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Veraxa Biotech Holding AG

交易所：

NASDAQ

成立时间：

2021

员工人数：

- -

公司地址：

Im Neuenheimer Feld 584,Heidelberg,Baden-Württemberg,Germany

官网：

http://www.veraxa.com

邮编：

69120

电话：

49 6221 3521330

传真：

- -

简介：

Veraxa Biotech AG于2025年6月25日在瑞士法律下注册成立。该公司是一家专注于肿瘤学的生物技术公司，拥有急性髓系白血病的临床项目，以及用于开发抗体药物偶联物和T细胞衔接器的专有平台技术。其目标是建立一个肿瘤学项目管线，旨在为患者实现疗效的同时最大限度地减少副作用。

董事

名称

职位

Adeel Rouf

President, Chief Executive Officer and Director

Warren Hosseinion

Chairman of the Board and Director

Jonathan Intrater

Independent Director

Oded Levy

Independent Director

股东

名称

职位

Adeel Rouf

President, Chief Executive Officer and Director

Carl von Halem

Interim Chief Financial Officer

Christoph Erkel

Chief Scientific Officer

Warren Hosseinion Jr.

Vice President, Mergers and Acquisitions

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/VRXA/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VRXA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRXA\",,,,,undefined,":{"symbol":"VRXA","market":"US","secType":"STK","nameCN":"Veraxa Biotech Holding AG","latestPrice":1.95,"timestamp":1787342400000,"preClose":1.89,"halted":0,"volume":80147,"hourTrading":{"tag":"盘前","latestPrice":2,"preClose":1.95,"latestTime":"04:00 EDT","volume":10,"amount":20,"timestamp":1787558415244,"change":0.05,"changeRate":0.025641,"amplitude":0},"delay":0,"changeRate":0.03174603174603178,"floatShares":41012504,"shares":141407813,"eps":0.2142,"marketStatus":"盘前交易","change":0.06,"latestTime":"08-24 06:28:49 EDT","open":1.86,"high":2,"low":1.8501,"amount":155628,"amplitude":0.079312,"askPrice":1.98,"askSize":50,"bidPrice":1.89,"bidSize":5,"shortable":3,"etf":0,"ttmEps":0.2142,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":1.95,"preHourTrading":{"tag":"盘前","latestPrice":2,"preClose":1.95,"latestTime":"04:00 EDT","volume":10,"amount":20,"timestamp":1787558415244,"change":0.05,"changeRate":0.025641,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.95,"preClose":1.95,"latestTime":"19:02 EDT","volume":146,"amount":283.17,"timestamp":1787353358074,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.967295187072036},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRXA\",,,,,undefined,":{"symbol":"VRXA","floatShares":41012504,"roa":"-20.46%","roe":"-65.29%","lyrEps":-2.209413,"volumeRatio":0.967295187072036,"shares":141407813,"dividePrice":0,"high":2,"amplitude":0.079312,"preClose":1.89,"low":1.8501,"week52Low":1.7,"pbRate":"7.12","week52High":27.36,"institutionHeld":0,"latestPrice":1.95,"committee":-0.818182,"eps":0.2142,"divideRate":0,"volume":80147,"delay":0,"ttmEps":0.2142,"open":1.86,"prevYearClose":18.65,"prevWeekClose":1.95,"prevMonthClose":1.76,"prevQuarterClose":1.88,"fiveDayClose":1.87,"twentyDayClose":1.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VRXA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VRXA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VRXA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VRXA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VRXA","date":"2026-08-21","current":9.103641,"percent":0,"low":-1.35335,"twenty":-1.349054,"median":-1.34261,"eighty":-1.336165,"high":-1.331869,"avg":-1.34261,"sd":0.010741,"marketCap":47660725},"quantilePoints":[{"date":"2026-08-21","current":-1.35335,"twenty":-1.349054,"median":-1.34261,"eighty":-1.336165,"marketCap":47660725}],"updateTime":1787538393554},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":699307581,"yearFounded":2021,"address":"Im Neuenheimer Feld 584,Heidelberg,Baden-Württemberg,Germany","zipCode":"69120","officePhone":"49 6221 3521330"},"stockCompanyDetail":{"websiteUrl":"http://www.veraxa.com","stockEarnings":[{"period":"1week","weight":0.0428},{"period":"1month","weight":-0.0488},{"period":"3month","weight":-0.8954},{"period":"ytd","weight":-0.8954}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Veraxa Biotech AG于2025年6月25日在瑞士法律下注册成立。该公司是一家专注于肿瘤学的生物技术公司，拥有急性髓系白血病的临床项目，以及用于开发抗体药物偶联物和T细胞衔接器的专有平台技术。其目标是建立一个肿瘤学项目管线，旨在为患者实现疗效的同时最大限度地减少副作用。","exchange":"NASDAQ","name":"Veraxa Biotech Holding AG","nameEN":"Veraxa Biotech Holding AG"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"VRXA\",market:\"US\",,,undefined,":{"directors":[{"name":"Adeel Rouf","position":"President, Chief Executive Officer and Director"},{"name":"Warren Hosseinion","position":"Chairman of the Board and Director"},{"name":"Jonathan Intrater","position":"Independent Director"},{"name":"Oded Levy","position":"Independent Director"}],"executives":[{"name":"Adeel Rouf","position":"President, Chief Executive Officer and Director"},{"name":"Carl von Halem","position":"Interim Chief Financial Officer"},{"name":"Christoph Erkel","position":"Chief Scientific Officer"},{"name":"Warren Hosseinion Jr.","position":"Vice President, Mergers and Acquisitions"}]}}}